February 28, 2022
The Israeli Company That Develops Treatment for Rare Diseases [Hebrew article] Download this news article Read More Read MoreSeptember 24, 2021
Minovia’s Preclinical Publication in Nature’s Journal of Regenerative Medicine on the Benefit Conferred by Mitochondrially-augmenetd CD34+ Cells in Patients with Mitochondrial Disorders Download this news article Read More Read MoreJuly 30, 2021
Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs Read More Read MoreApril 27-29, 2021
Minovia Therapeutics’ CEO Natalie Yivgi-Ohana to present at the Mitochondria-Targeted Drug Development Conference April 27-29, 2021 Read More Read MoreMarch 12, 2021
Minovia Therapeutics Announces Appointment of Alan Jacobs, MSEE, MD, PhD as Chief Medical Officer Download this news article Read More Read MoreNovember 23, 2020
Minovia Therapeutics Announces Manufacturing Partnership with BioSpherix and Appoints David O’Donnell as Global Head of Manufacturing and Supply Chain Download this news article Read MoreNovember 9, 2020
Minovia Therapeutics to Participate at Upcoming Credit Suisse Healthcare Conference on November 12th Read More Read MoreJune 26, 2019
Minovia Therapeutics Announces Dosing of Patient in First Mitochondrial Cell Therapy Trial for the Treatment of Pearson Syndrome & Names John Cox as Executive Chairman Download this news article Read More Read More